|
Real-time
Euronext Paris
08:56:32 2026-11-18 EST
|
5-day change | 1st Jan Change | ||
| 0.4305 EUR | -0.81% |
|
-2.16% | +10.10% |
| 11-11 | Novacyt Secures Australian Regulatory Clearance for Yourgene Insight Diagnostic Assay | MT |
| 11-11 | Novacyt's Yourgene test authorized in Australia |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NOVACYT | Bio Medical Devices | -0.81% | -2.16% | +10.10% | -1.03% | -85.93% | 34.66M |
- Stock Market
- Stocks
- ALNOV Stock
- Charts Novacyt
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
















